Anka G. Ehrhardt PhD

Dr. Anka Ehrhardt is a biophysicist with a doctorate degree in human physiology. Throughout her career, Dr. Ehrhardt combined technical expertise with strategic excellence and operational savvy to build and run laboratories and teams, drive them to become Centers of Excellence and key partners, serving the discovery and development needs of large biopharmaceutical companies. Through her work at Merck and BMS, Dr. Ehrhardt encountered the key issues in biopharma research and development; the specific challenges in different ways of sample and data collection, and the importance of strategic planning and analysis.

Based on observed needs, Dr. Ehrhardt lead teams of increasing size in developing and implementing strategies reaching from securing that biomarker assays are optimized to gather clear data in support of fast, well-founded decision making, to systematically maximizing the information gathered from clinical samples in support of hypothesis generation. She joined CHDI in 2017.